Cargando…

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

Circulating levels of fibroblast growth factor 23 (FGF23) are elevated in patients with chronic kidney disease (CKD), but the mechanisms are poorly understood. Here we tested whether inflammation and iron deficiency regulate FGF23. In wild-type mice, acute inflammation induced by single injections o...

Descripción completa

Detalles Bibliográficos
Autores principales:	David, Valentin, Martin, Aline, Isakova, Tamara, Spaulding, Christina, Qi, Lixin, Ramirez, Veronica, Zumbrennen-Bullough, Kimberly B., Sun, Chia Chi, Lin, Herbert Y., Babitt, Jodie L., Wolf, Myles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854810/ https://www.ncbi.nlm.nih.gov/pubmed/26535997 http://dx.doi.org/10.1038/ki.2015.290

Ejemplares similares

Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease
por: Courbon, Guillaume, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
por: Dussold, Corey, et al.
Publicado: (2019)

Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
por: Core, Amanda B., et al.
Publicado: (2014)

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)

Abnormal Brain Iron Metabolism in Irp2 Deficient Mice Is Associated with Mild Neurological and Behavioral Impairments
por: Zumbrennen-Bullough, Kimberly B., et al.
Publicado: (2014)

Repulsive Guidance Molecule (RGM) Family Proteins Exhibit Differential Binding Kinetics for Bone Morphogenetic Proteins (BMPs)
por: Wu, Qifang, et al.
Publicado: (2012)

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
por: Edmonston, Daniel, et al.
Publicado: (2023)

The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism
por: Braithwaite, V.S., et al.
Publicado: (2016)

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
por: Scialla, Julia J., et al.
Publicado: (2013)

Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
por: Courbon, Guillaume, et al.
Publicado: (2023)

Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort
por: Sunderraj, Ashwin, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Leidner, Alexander S., et al.
Publicado: (2023)

Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis
por: Schaefer, Benedikt, et al.
Publicado: (2020)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Iron status and fibroblast growth factor-23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2012)

Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification
por: Santos, Maria C. Ferreira dos, et al.
Publicado: (2020)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019)

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
por: Wolf, Myles, et al.
Publicado: (2020)

Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes
por: Marebwa, Barbara K., et al.
Publicado: (2018)

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis
por: Wolf, Myles, et al.
Publicado: (2019)

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling
por: Czaya, Brian, et al.
Publicado: (2022)

Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
por: Roberts, Matthew A., et al.
Publicado: (2016)

High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23
por: Dahlerup, Jens Frederik, et al.
Publicado: (2016)

Inflammation Regulates TMPRSS6 Expression via STAT5
por: Meynard, Delphine, et al.
Publicado: (2013)

Fibroblast growth factor 23, iron and inflammation – are they related in early stages of chronic kidney disease?
por: Lukaszyk, Ewelina, et al.
Publicado: (2016)

Long‐Term Effects of Sglt2 Deletion on Bone and Mineral Metabolism in Mice
por: Gerber, Claire, et al.
Publicado: (2021)

Iron regulatory protein deficiency compromises mitochondrial function in murine embryonic fibroblasts
por: Li, Huihui, et al.
Publicado: (2018)

Hepcidin Regulation by BMP Signaling in Macrophages Is Lipopolysaccharide Dependent
por: Wu, Xinggang, et al.
Publicado: (2012)

Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
por: Fernández-Real, José Manuel, et al.
Publicado: (2013)

The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans
por: Bielesz, Bernhard, et al.
Publicado: (2020)

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022)

FGF-23: More Than a Regulator of Renal Phosphate Handling?
por: Jüppner, Harald, et al.
Publicado: (2010)

Iron deficiency and iron deficiency anemia in pregnancy
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
por: Glaspy, John A., et al.
Publicado: (2021)

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis
por: Edmonston, Daniel L., et al.
Publicado: (2021)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfv9fs2ivfhv5ine6m510b1emq